Cargando…
Assessment of Strategies for Safe Drug Discontinuation and Transition of Denosumab Treatment in PMO—Insights From a Mechanistic PK/PD Model of Bone Turnover
Denosumab (Dmab) treatment against postmenopausal osteoporosis (PMO) has proven very efficient in increasing bone mineral density (BMD) and reducing the risk of bone fractures. However, concerns have been recently raised regarding safety when drug treatment is discontinued. Mechanistic pharmacokinet...
Autores principales: | Martínez-Reina, Javier, Calvo-Gallego, José Luis, Martin, Madge, Pivonka, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367195/ https://www.ncbi.nlm.nih.gov/pubmed/35966026 http://dx.doi.org/10.3389/fbioe.2022.886579 |
Ejemplares similares
-
Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response
por: Calvo-Gallego, José L., et al.
Publicado: (2022) -
Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
por: Martínez-Reina, Javier, et al.
Publicado: (2021) -
Spatio-temporal simulations of bone remodelling using a bone cell population model based on cell availability
por: Calvo-Gallego, José Luis, et al.
Publicado: (2023) -
Editorial: Bone integrity in patients with osteoporosis: Evaluation of fracture risk and influence of pharmacological treatments and mechanical aspects
por: Martínez-Reina, Javier, et al.
Publicado: (2023) -
Toward Patient Specific Models of Pediatric IVDs: A Parametric Study of IVD Mechanical Properties
por: Pickering, Edmund, et al.
Publicado: (2021)